We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLSK icon
551
CleanSpark
CLSK
$3.16B
– –
-19,443
Closed -$131K
CLX icon
552
Clorox
CLX
$12.7B
– –
-4,047
Closed -$596K
CMP icon
553
Compass Minerals
CMP
$1.15B
– –
-38,550
Closed -$358K
CNX icon
554
CNX Resources
CNX
$5.2B
– –
-7,548
Closed -$238K
COHR icon
555
Coherent
COHR
$74.2B
– –
-8,415
Closed -$546K
COIN icon
556
Coinbase
COIN
$40.5B
– –
-4,871
Closed -$839K
COLL icon
557
Collegium Pharmaceutical
COLL
$956M
– –
-7,737
Closed -$231K
COOP
558
DELISTED
Mr. Cooper
COOP
– –
-7,426
Closed -$888K
CORT icon
559
Corcept Therapeutics
CORT
$12B
– –
-1,984
Closed -$227K
COUR icon
560
Coursera
COUR
$1.54B
– –
-23,580
Closed -$157K
COTY icon
561
Coty
COTY
$2.48B
– –
-48,078
Closed -$263K
CPT icon
562
Camden Property Trust
CPT
$11.3B
– –
-3,655
Closed -$447K
CRGX
563
DELISTED
CARGO Therapeutics
CRGX
– –
-20,602
Closed -$83.8K
CRGY icon
564
Crescent Energy
CRGY
$3.82B
– –
-12,667
Closed -$142K
CRNC icon
565
Cerence
CRNC
$413M
– –
-23,188
Closed -$183K
CSTL icon
566
Castle Biosciences
CSTL
$979M
– –
-19,439
Closed -$389K
CSX icon
567
CSX Corp
CSX
$93.1B
– –
-10,806
Closed -$318K
CTKB icon
568
Cytek Biosciences
CTKB
$546M
– –
-22,314
Closed -$89.5K
CVGW
569
DELISTED
Calavo Growers
CVGW
– –
-18,163
Closed -$436K
CVX icon
570
Chevron
CVX
$366B
– –
-2,818
Closed -$471K
CWH icon
571
Camping World
CWH
$653M
– –
-18,133
Closed -$293K
CYH icon
572
Community Health Systems
CYH
$423M
– –
-42,648
Closed -$115K
D icon
573
Dominion Energy
D
$59.3B
– –
-14,270
Closed -$800K
DAL icon
574
Delta Air Lines
DAL
$60.1B
– –
-8,703
Closed -$379K
DAR icon
575
Darling Ingredients
DAR
$9.44B
– –
-13,571
Closed -$424K
21 22
23
24 25

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.